Related Experiment Video
Updated: Jul 7, 2026

Cardiac Catheterization in Mice to Measure the Pressure Volume Relationship: Investigating the Bowditch Effect
Published on: June 14, 2015
Natriuretic peptides and filling pressure at rest and stress
Manish Bansal1, Thomas H Marwick
1University of Queensland, Brisbane, Australia.
Insights
Natriuretic peptides, released by the heart, can indicate left-ventricular filling pressure. However, their levels may be unreliable in severe heart failure or mild diastolic dysfunction, complicating diagnosis.
Area of Science:
- Cardiology
- Biochemistry
Background:
- Natriuretic peptides are secreted by the heart in response to stress, tachycardia, and ischemia.
- Elevated natriuretic peptide levels correlate with increased left-ventricular filling pressure in systolic dysfunction.
Purpose of the Study:
- To explore the utility of natriuretic peptides in assessing diastolic dysfunction.
- To investigate the challenges in interpreting natriuretic peptide levels due to variability.
Main Methods:
- Review of existing literature on natriuretic peptides and heart dysfunction.
- Analysis of correlations between natriuretic peptides and filling pressures in various heart failure types.
Main Results:
- Natriuretic peptide levels correlate with left-ventricular filling pressure in systolic dysfunction.
- Association with diastolic dysfunction is variable; many with mild dysfunction show no elevation.
- Severely impaired ventricles may produce lower peptide levels, complicating interpretation in severe heart failure.
Conclusions:
- Natriuretic peptides are valuable indicators in systolic dysfunction but less reliable in diastolic dysfunction.
- Variability in peptide levels poses challenges for monitoring exercise or therapy response.
- Echocardiography may be a more consistent tool for assessing filling pressures in mild diastolic dysfunction.
Abstract:
The natriuretic peptides are a family of compounds secreted from the atria and ventricles in response to a variety of stimuli, including increased wall stress, tachycardia, and myocardial ischemia. Increases in the levels of these compounds correlate with increased left-ventricular filling pressure in patients with systolic dysfunction, although the production of the compounds from severely impaired ventricles may be reduced, leading to lower than anticipated levels in severe heart failure. The association of increased natriuretic peptides with diastolic dysfunction has been variable, with no elevation reported in many patients with mild dysfunction. These patients with mild diastolic dysfunction become symptomatic with exercise, in association with increased filling pressure with stress, which may be documented using echocardiography or possibly the natriuretic peptide response. However, the variability of peptide levels within individuals may pose a problem to the interpretation of sequential data in response to exercise or therapies.
Related Concept Videos
Hormonal Regulation of Blood Pressure
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
Heart Failure II: Pathophysiology
Hormonal Regulation
Heart Failure Drugs: Diuretics
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Regulation of Sodium and Potassium
Sodium Regulation
Sodium ions make up approximately 90% of extracellular cations, with a normal blood plasma concentration of 136–148 mEq/L. A decrease in blood volume and pressure triggers the release of renin from granular cells in the juxtaglomerular complex (JGC), primarily in...

